Nutrien (NYSE:NTR – Get Rating) had its price target reduced by investment analysts at JPMorgan Chase & Co. from $92.00 to $78.00 in a research note issued on Friday, The Fly reports. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 25.91% from the company’s previous close.
Other equities research analysts have also recently issued research reports about the stock. Morgan Stanley decreased their target price on shares of Nutrien from $91.00 to $80.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 12th. Barclays decreased their price target on shares of Nutrien from $93.00 to $80.00 in a report on Friday, May 12th. Royal Bank of Canada decreased their price target on shares of Nutrien from $100.00 to $95.00 in a report on Friday, May 12th. Berenberg Bank cut shares of Nutrien from a “buy” rating to a “hold” rating and decreased their price target for the stock from $92.00 to $49.00 in a report on Wednesday. Finally, UBS Group decreased their price target on shares of Nutrien from $100.00 to $99.00 and set a “buy” rating for the company in a report on Thursday, April 6th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $80.35.
Nutrien Trading Up 0.8 %
NYSE:NTR opened at $61.95 on Friday. Nutrien has a 52 week low of $58.75 and a 52 week high of $103.20. The firm has a 50 day moving average of $69.74 and a 200 day moving average of $74.79. The company has a quick ratio of 0.61, a current ratio of 1.18 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $30.73 billion, a price-to-earnings ratio of 4.86, a PEG ratio of 0.89 and a beta of 0.88.
Institutional Trading of Nutrien
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD grew its position in Nutrien by 3.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 22,758,328 shares of the company’s stock valued at $1,680,704,000 after buying an additional 773,028 shares during the period. Bank of America Corp DE grew its position in Nutrien by 49.8% during the first quarter. Bank of America Corp DE now owns 19,638,296 shares of the company’s stock valued at $1,450,288,000 after buying an additional 6,525,006 shares during the period. Vanguard Group Inc. grew its position in shares of Nutrien by 0.7% in the third quarter. Vanguard Group Inc. now owns 18,309,215 shares of the company’s stock valued at $1,526,621,000 after purchasing an additional 129,212 shares during the period. Deutsche Bank AG grew its position in shares of Nutrien by 6.3% in the first quarter. Deutsche Bank AG now owns 15,152,334 shares of the company’s stock valued at $1,119,000,000 after purchasing an additional 898,671 shares during the period. Finally, Dodge & Cox grew its position in shares of Nutrien by 7.3% in the first quarter. Dodge & Cox now owns 11,533,359 shares of the company’s stock valued at $851,739,000 after purchasing an additional 789,300 shares during the period. Institutional investors and hedge funds own 64.52% of the company’s stock.
Nutrien Company Profile
Nutrien Ltd. is a crop nutrient company, which engages in the production and distribution of products for agricultural, industrial, and feed customer. It operates through the following segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed, and merchandise.
- Get a free copy of the StockNews.com research report on Nutrien (NTR)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.